Dimethyltryptamine

二甲基色胺

Report date: 2024/03/28 17:42:07
NME

Base Information

Drug NameDimethyltryptamine
Drug Alias NameSPL-026
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor agonists
TargetsSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsDepressive Disorder, MajorCognitionEmpathy +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerlandUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSmall Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYale UniversityJohns Hopkins UniversityPsychiatric University Clinic Zurich +[4] 
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, MajorCognitionEmpathy +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A